Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a ...

NervGen Pharma (TSE:NGEN) has released an update. NervGen Pharma, a clinical-stage biotech company, is set to present at the Stifel 2024 ...

Target enrollment in the chronic cohort close to completionVancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage ...

Featured here, the Balance Sheet for NervGen Pharma Corp, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...

Keywood covers the Healthcare sector, focusing on stocks such as Cipher Pharmaceuticals, Knight Therapeutics, and NervGen Pharma. According to TipRanks, Keywood has an average return of -3.4% and ...

A screenshot of the ABC News-hosted presidential debate between Kamala Harris and Donald Trump in September 2024. Picture: Youtube screenshot of Wall Street Journal debate stream Half of the world ...

Vancouver, BC, October 10, 2024--(T-Net)--NervGen Pharma Corp. (TSX-V: NGEN), a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, ...

However, promising candidates like Lineage Cell Therapeutics’ OPC1 and NervGen’s NVG-291 are currently in the pipeline, offering hope for future therapeutic options. Mike Kelly, chief executive ...

Vancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions ...

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...